Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;45(1):102-114.
doi: 10.1177/0271678X241270445. Epub 2024 Aug 7.

Plasminogen activator inhibitor-1 mediates cerebral ischemia-induced astrocytic reactivity

Affiliations

Plasminogen activator inhibitor-1 mediates cerebral ischemia-induced astrocytic reactivity

Pavel Yanev et al. J Cereb Blood Flow Metab. 2025 Jan.

Abstract

Although ischemia increases the abundance of plasminogen activator inhibitor-1 (PAI-1), its source and role in the ischemic brain remain unclear. We detected PAI-1-immunoreactive cells with morphological features of reactive astrocytes in the peri-ischemic cortex of mice after an experimentally-induced ischemic lesion, and of a chimpanzee that suffered a naturally-occurring stroke. We found that although the abundance of PAI-1 increases 24 hours after the onset of the ischemic injury in a non-reperfusion murine model of ischemic stroke, at that time-point there is no difference in astrocytic reactivity and the volume of the ischemic lesion between wild-type (Wt) animals and in mice either genetically deficient (PAI-1-/-) or overexpressing PAI-1 (PAI-1Tg). In contrast, 72 hours later astrocytic reactivity and the volume of the ischemic lesion were decreased in PAI-1-/- mice and increased in PAI-1Tg animals. Our immunoblottings and fractal analysis studies show that the abundance of astrocytic PAI-1 rises during the recovery phase from a hypoxic injury, which in turn increases the abundance of glial fibrillary acidic protein (GFAP) and triggers morphological features of reactive astrocytes. These studies indicate that cerebral ischemia-induced release of astrocytic PAI-1 triggers astrocytic reactivity associated with enlargement of the necrotic core.

Keywords: Plasminogen activator inhibitor-1 (PAI-1); astrocytic reactivity; cerebral ischemia; fractal analysis; glial fibrillary acidic protein (GFAP).

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Cerebral ischemia increases the abundance of PAI-1 in the ischemic tissue. (a) Representative TTC staining in the brain of a wild-type (Wt) mouse 24 hours after the induction of a photothrombotic lesion to the left frontal cortex (depicted by black arrows). (b) PAI-1 concentration in the ischemic tissue of Wt mice (n = 5) 24 hours after the induction of an ischemic lesion performed as described in A. Results were normalized to PAI-1 concentration in a comparable area from the contralateral non-ischemic hemisphere. Statistical analysis: two-tailed Student’s t-test and non-parametric Mann-Whitney. t = 2.958, df: 7 and (c) PAI-1 mRNA abundance in the ischemic tissue of Wt mice exposed to the experimental conditions described in B. n = 4 per experimental group. Statistical analysis: two-tailed Student’s t-test. t = 2.600, df: 6.
Figure 2.
Figure 2.
Effect of cerebral ischemia on astrocytic PAI-1. (a) Sagittal (a), coronal (b) and axial (c) T2 weighted images from the brain of a 50 year/old female chimpanzee harvested after clinical euthanasia following the spontaneous development of left hemiparesis. (b) Panel a corresponds to a representative micrograph at 20X magnification from a brain section obtained from the area surrounding the necrotic core (asterisks in A-panel a) and stained with antibodies against PAI-1. N depicts part of the necrotic area. R1, R2 & R3 correspond to regions of interest at different distances from N where the expression of PAI-1 was examined. Panels b, d & f show representative micrographs at 40X magnification from R1, R2 and R3, respectively. Panels c, e & g correspond to a 3X electronic magnification of the areas depicted by the dashed squares in b, d & f. Arrows denote examples of PAI-1-immunoreactive cells with morphological features of astrocytes and (c) panel a corresponds to a representative micrograph at 20X magnification from a brain section stained with anti-PAI-1 antibodies in a wild-type mouse 72 hours after the induction of a photothrombotic ischemic lesion to the left M1 area. R1, R2 & R3 correspond to regions of interest at different distance from the necrotic core were the expression of PAI-1 was examined. Panels b, c & d are micrographs at 40X magnification from R1, R2 and R3, respectively. Arrows in b and c denote examples of PAI-1 immunoreactive cells with morphological features of astrocytes.
Figure 3.
Figure 3.
PAI-1 mediates cerebral ischemia-induced astrocytic activation. (a) Representative micrographs from the brain of Wt, PAI-1 deficient (PAI-1−/−) and PAI-1 transgenic (PAI-1Tg) mice stained with anti-GFAP antibodies (green) 24 hours after the induction of an ischemic lesion as described in A. (b) Volume of the ischemic lesion in TTC-stained sections from Wt, PAI-1−/− and PAI-1Tg mice 24 hours after an ischemic stroke induced as presented in panel A. n = 7 per experimental condition. Statistical analysis: one-way ANOVA with Tukey’s multiple comparison’s test. 95% CI: −5.020 to 4.429 for Ct vs PAI-1−/−, and −5.859 to 3.590 for Wt vs PAI-1Tg. (c & d) Representative Western blot analysis (A) and quantification of the intensity of the band (b) of GFAP expression in the ischemic tissue of Wt (n = 6) and PAI-1−/− (n = 8) mice 72 hours after the induction of a photothrombotic lesion to the frontal cortex. Statistical analysis: two-tail Student’s t-test and non-parametric Mann-Whitney. T = 2.473 and df = 12. (e) Representative micrographs from the brain of Wt, PAI-1 deficient (PAI-1−/−) and PAI-1 transgenic (PAI-1Tg) mice stained with anti-GFAP antibodies (green) 72 hours after the induction of an ischemic lesion to the frontal cortex. Panels b, d and f correspond to a 3X magnification of the area surrounding the ischemic core. (f) Quantification of GFAP-immunoreactive area in the ischemic hemisphere of Wt, PAI-1−/− and PAI-1Tg mice exposed to the experimental conditions described in C. Each point is the average of quantifications obtained in four different pictures from 6 different brains per experimental condition. Statistical analysis: one-way ANOVA with Tukey’s multiple comparisons test. 95% CI: 28.85 to 241.7 for Wt vs PAI-1−/−, −214.1 to −1.229 for Wt vs PAI-1Tg, and −349.4 to −136.5 for PAI-1−/− vs PAI-1Tg and (g) volume of the ischemic lesion in TTC-stained sections from Wt, PAI-1−/− and PAI-1Tg mice 4 days after the induction of a photothrombotic lesion to the left frontal cortex. n = 9 per experimental condition. Statistical analysis: one-way ANOVA with Tukey’s multiple comparisons test (95% CI: 1.464 to 14.40 for Wt Vs PAI-1−/−, −16.88 to −3.945 for Wt vs PAI-1Tg, and −25.00 to −11.69 for PAI-1−/− vs PAI-1Tg).
Figure 4.
Figure 4.
Effect of hypoxia on astrocytic PAI-1. (a) Representative micrographs at 40X magnification of PAI-1 (red) and Hoechst (blue) staining in wild-type astrocytes maintained under physiological conditions (a), or fixed either 6 h (b), or 24 h (c), or 48 h (d) after 60 minutes of exposure to oxygen and glucose deprivation (OGD) conditions. Panels e, f, g & h correspond to a 1.5 electronic magnification of the areas depicted by the dashed squares in a, b, c & d, respectively. Arrowheads in f, g & h depict examples of astrocytic elongations and peripheral astrocytic processes. (b) Intensity of PAI-1 immunoreactivity normalized to area in astrocytes exposed to the experimental conditions described in A. n = 15 per experimental group. Statistical analysis: one-way ANOVA with Tukey’s multiple comparisons test. 95% CI: −5265 to −1973 for controls vs 6 h, −5289 to −1997 for controls vs 24 hours, −3973 to −501.6 for controls vs 48 h. (c) Fold increase in the abundance of PAI-1 mRNA in astrocytes extracted 24 hours after 60 minutes of exposure to OGD conditions compared to cells maintained under normoxic conditions (control: c). n = 12 per experimental group. Statistical analysis: two-tailed Student’s t-test and non-parametric Mann-Whitney test. t = 4.075. df = 22. (d) PAI-1 concentration (ELISA) in the culture medium of wild-type astrocytes kept under physiological conditions (c), or 24 hours after 60 minutes of exposure to OGD. n = 12 per experimental condition. Statistical analysis: one-tailed Student’s t-test, non-parametric Mann – Whitney test. t = 2.911, df = 24.
Figure 5.
Figure 5.
PAI-1 mediates hypoxia-induced astrocytic activation. Representative Western blot analysis (a) and quantification of the intensity of the band (b) of GFAP expression in Wt and PAI-1−/− astrocytes maintained under normoxic conditions (control: c) or extracted 24 hours after 60 minutes of exposure to oxygen and glucose deprivation (OGD) conditions. n = 6 per experimental condition. Statistical analysis one-way ANOVA with Tukey’s multiple comparisons test. For Wt control vs Wt OGD, 95% CI: −68.66 to −23.58. For PAI-1−/−control vs PAI-1−/− OGD, 95% CI: −15.84 to 29.24.
Figure 6.
Figure 6.
PAI-1 mediates hypoxia-induced changes on astrocytic morphology. Wt (a & b) and PAI-1−/− (c & d) astrocytes kept under physiological conditions (control: C) or fixed 24 hours after 60 minutes of exposure to oxygen and glucose deprivation (OGD) were stained with anti-ezrin antibodies (green in a & b). Pictures of individual cells were taken at 20X magnification and covered by a grid of boxes (panels c & d) to quantify changes in cell complexity and shape with FracLac - Image J (fractal dimension in panels b and d). Each dot in b & d corresponds to the average of quantifications performed on 40 cells from 4 different cultures for each experimental condition. Statistical analysis in B & D: two-tailed unpaired Student’s t-test, and non-parametric Mann-Whitney test. For B, t = 2.913 and df = 6. For D, t = 0.4230 and df = 6.

References

    1. Robbins KC, Summaria L, Hsieh B, et al. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. J Biol Chem 1967; 242: 2333–2342. 1967/05/25. - PubMed
    1. Hart DA, Rehemtulla A. Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function. Comp Biochem Physiol B 1988; 90: 691–708. - PubMed
    1. Dosne AM, Dupuy E, Bodevin E. Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein. Thromb Res 1978; 12: 377–387. - PubMed
    1. Fisher M, Francis R. Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity. Arch Neurol 1990; 47: 1075–1079. - PubMed
    1. Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. JClinInvest 1991; 88: 1346–1353. - PMC - PubMed

Substances

LinkOut - more resources